Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


France's Agency Chief Quits Over Servier Drug Safety Furor

This article was originally published in The Pink Sheet Daily

Executive Summary

Jean Marimbert's resignation over the Mediator affair also highlights larger issues of regulatory transparency and better pharmacovigilance.

Related Content

French Drug Industry Group Kicked Off Key Gov't Committee
France Suspends Bayer Diane 35: Post-Mediator Strictness Or Prelude To Broad Withdrawal?
EMA Moves To Reassure Europe Over Combined Contraceptives
Mediator Scandal Provokes Flurry of French Health Reforms But Impact Is Hard To Gauge Until The Dust Settles
European Regulatory Round-Up: Patents, Pricing And Parabens
Questioning Authority: French Court Overturns Health Agency's Diabetes Guidelines, Citing Conflict Of Interest Rules
France Proposes Mediator Injury Compensation Program, Pressuring Servier To Fund It
European Regulatory Round-Up
France's Drug Risk List Could Prompt Patients To Seek Alternatives
Improved EU Pharmacovigilance May Not Prevent Another Mediator





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts